SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-24-008576 from IN8BIO, INC. (INAB) (CIK 0001740279) (INAB)

IN8BIO, INC. (INAB) (CIK 0001740279)
Date: Jan. 16, 2024 · CIK: 0001740279 · Accession: 0001193125-24-008576

AI Filing Summary & Sentiment

File numbers found in text: 333-276504

Date
January 16, 2024
Author
Not clearly detected
Form
CORRESP
Company
IN8BIO, INC. (INAB) (CIK 0001740279)

Letter

IN8BIO, INC.

350 5th Avenue, Suite 5330

New York, New York 10118

January 16, 2024

VIA EDGAR

Securities and Exchange Commission

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attn: Daniel Crawford

Re:

IN8bio, Inc. (CIK No. 0001740279)

Registration Statement on Form S-3

File No. 333-276504

Request for Acceleration of Effective Date

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, IN8bio, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) to become effective as of 4:00 p.m. Eastern time, on January 18, 2024, or as soon thereafter as possible, or at such other time as its legal counsel, Cooley LLP, may request by telephone to the Staff.

Once the Registration Statement has been declared effective, please confirm that event with Sarah Curry of Cooley LLP by phone at (212) 479-6652 or by e-mail at sarah.curry@cooley.com.

[Signature page follows]

Very truly yours,
IN8bio, Inc.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 IN8BIO, INC.

350 5th Avenue, Suite 5330

New York, New York 10118

 January 16, 2024

 VIA EDGAR

 Securities and Exchange
Commission

 Office of Life Sciences

 100 F Street, N.E.

Washington, D.C. 20549

 Attn: Daniel Crawford

Re:

 IN8bio, Inc. (CIK No. 0001740279)

Registration Statement on Form S-3

File No. 333-276504

Request for Acceleration of Effective Date

 Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, IN8bio, Inc. (the
“Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form
S-3 (the “Registration Statement”) to become effective as of 4:00 p.m. Eastern time, on January 18, 2024, or as soon thereafter as possible, or at such other time as its legal counsel,
Cooley LLP, may request by telephone to the Staff.

 Once the Registration Statement has been declared effective, please confirm that event
with Sarah Curry of Cooley LLP by phone at (212) 479-6652 or by e-mail at sarah.curry@cooley.com.

[Signature page follows]

Very truly yours,

IN8bio, Inc.

 /s/ William Ho

By:

William Ho

Title:

President and Chief Executive Officer

 [Signature Page to Acceleration Request]